City

Anchorage (1)

Basel (1)

Charlottesville (1)

Duncansville (1)

Nijmegen (1)

Overall Status

Not yet recruiting (3)

Recruiting (2)

Phase

phase 2 (2)

early phase 1 (1)

phase 1/phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Olatec Therapeutics LLC (2)

April Salama, M.D. (1)

University Hospital, Basel, Switzerland (1)

University of Virginia (1)

Collaborator

Olatec Therapeutics LLC (2)

European Union (Horizon Europe Programme) (1)

Merck Sharp & Dohme LLC (1)

Radboud University Medical Center (1)

State Secretariat for Education Research and Innovation, Switzerland (1)

Intervention

dapansutrile (5)

placebo (2)

pembrolizumab (1)

placebo tablet (1)

Study Documents

Intervention Type

drug (5)

other (2)

Funder Type

Other (3)

Industry (2)

Study Type

Interventional (5)

dapansutrile

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Type 2 Trial in Basel (Dapansutrile, Placebo)

Not yet recruiting

Diabetes Mellitus, Type 2

Dapansutrile
Placebo

Basel, Switzerland

University Hospital Basel

Sep 21, 2023

Acute Gout Flare, Gout Attack, Gout Flare Trial in Anchorage, Duncansville (Dapansutrile, Placebo Tablet)

Recruiting

Acute Gout Flare
+6 more

Dapansutrile
Placebo Tablet

Anchorage, Alaska
+1 more

Jan 19, 2023

Melanoma Trial (Dapansutrile, Pembrolizumab)

Not yet recruiting

Melanoma

Dapansutrile
Pembrolizumab

(no location specified)

Jul 26, 2022

Myocardial Infarction Trial in Charlottesville (Dapansutrile, Placebo)

Not yet recruiting

Myocardial Infarction

Dapansutrile
Placebo

Charlottesville, Virginia

University of Virginia

May 19, 2023

Schnitzler Syndrome Trial in Nijmegen (dapansutrile)

Recruiting

Schnitzler Syndrome

dapansutrile

Nijmegen, Netherlands

Radboudumc

Jul 1, 2021